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ORIGINAL ARTICLE
Coronary artery disease (CAD) is the leading
cause of death and a major cause of disability 
in women.1 However, the diagnosis of CAD in
women presents a greater challenge than in men.
It has been documented that the diagnostic 
accuracy of exercise electrocardiography (ECG)
for detecting CAD in women remains unsatisfac-
tory.2,3 Factors that influence gender differences in
the accuracy of diagnostic testing include a lower
prevalence of CAD,3,4 more single vessel disease
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Background/Purpose: The diagnosis of coronary artery disease (CAD) in women presents a great chal-
lenge because of poor exercise capacity and inadequate heart rate response during stress test. The clinical
significance of stress-related ST-segment/heart rate slope (ST/HR slope) value for evaluating CAD in women
remains controversial. Therefore, we conducted the present study to assess the diagnostic performance of
dobutamine ST/HR slope in women, compared with myocardial perfusion study using thallium-201 single-
photon emission computed tomography (Tl-201 SPECT).
Methods: A total of 51 female patients with suspected CAD underwent simultaneous 12-lead electrocardio-
graphic recording during 3-minute stages of dobutamine infusion as well as Tl-201 SPECT, and coronary
angiography was performed within 2 weeks post Tl-201 SPECT. The sensitivity, specificity, positive predic-
tive value and negative predictive value of dobutamine ST/HR slope and Tl-201 SPECT were assessed, and
the results of coronary angiography were used as a gold standard.
Results: The sensitivity, specificity and accuracy of dobutamine ST/HR slope in detecting CAD were 43%,
83% and 61%, and those of Tl-201 SPECT were 71%, 87% and 78%, respectively. However, using both
positive results of Tl-201 SPECT and ST/HR slope for detecting CAD, the diagnostic specificity increased
from 87% to 96%. Using both negative results of Tl-201 SPECT and ST/HR slope to exclude CAD, the neg-
ative predictive value increased from 71% to 85%. The accuracy of dobutamine ST/HR slope in detecting
CAD was not affected by the use of beta-blockers.
Conclusion: Dobutamine ST/HR slope is less sensitive and less accurate than Tl-201 SPECT for detecting
CAD in women. However, it adds diagnostic benefit to Tl-201 SPECT with only a little extra calculation. 
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compared with men,5,6 and features intrinsic to the
testing procedure itself.7,8 To achieve optimal diag-
nostic efficacy, maximal exercise must be used.9
However, women are less likely to achieve an ad-
equate heart rate response and are generally older
at the time of CAD diagnosis than men. In addi-
tion, the comorbidities associated with age, such
as neurologic, orthopedic and peripheral vascular
complications, also limit the level of maximal exer-
cise and the extent of exercise-induced myocardial
ischemia.10 Therefore, pharmacological stress test
has emerged as an important alternative for those
who cannot exercise adequately. Among pharma-
cological agents, dobutamine is one of the com-
monly employed stressors.11 On the other hand,
myocardial perfusion scan has been shown to im-
prove the efficacy of diagnosing CAD.12 However,
soft tissue attenuation in myocardial perfusion
imaging often causes false-positive results,13 which
needs more expensive hardware and requires
longer imaging time to correct the artifacts.14
Recently, some studies have demonstrated that
the linear regression-based ST-segment/heart rate
slope (ST/HR slope) may improve the diagnostic
accuracy of exercise ECG for detecting CAD in
women.4–6 However, the diagnostic role of dobu-
tamine ST/HR slope in detecting CAD in women
has not yet been studied. Therefore, we conducted
the present study firstly to assess the diagnostic
efficacy of dobutamine ST/HR slope for detecting
CAD in women, and secondly to assess its addi-
tional diagnostic value in the detection of CAD
in combination with thallium (Tl)-201 single-
photon emission computed tomography (SPECT)
in women.
Patients and Methods
Study population
Data of simultaneous dobutamine ECG and Tl-201
SPECT were obtained in 58 female patients with
chest discomfort referred for cardiac catheteri-
zation. Coronary angiography was performed in
these patients within 2 weeks. The pretest likeli-
hood of CAD was calculated according to age,
sex and symptoms.15 Seven of the 58 patients
were excluded from analysis because resting ECG
showed right or left bundle branch block, ST 
elevation with Q waves or inadequate recording
of ECG. A total of 51 patients were included in
this study.
Dobutamine infusion protocol
Dobutamine was infused intravenously at a rate
of 5, 10, 20, 30 and 40 µg/kg/min using 3-minute
stages as previously described.16,17 Reasons for
termination were: severe hypertension (systolic
blood pressure > 220 mmHg or diastolic blood
pressure > 110 mmHg), a symptomatic decrease in
blood pressure (compared with baseline blood
pressure before dobutamine infusion), prolonged
angina, any significant arrhythmia, chest pain with
the development of ST-segment depression on the
ECG, achievement of 85% of the age-predicted
maximal heart rate, or completion of the maximal
dose of 40 µg/kg/min. Patients were observed for
10 minutes after infusion. Blood pressure, heart
rate, symptoms and 12-lead ECG were recorded
at baseline, the last minute of each stage and at
the end of the recovery period. Beta-blockers were
not discontinued before dobutamine thallium
scintigraphy.
Dobutamine thallium SPECT
Two to 3 mCi of Tl-201 was injected intravenously
at the third minute of peak phase of dobutamine
infusion. Myocardial SPECT was carried out within
10 minutes (stress phase) and at 4 hours (redis-
tribution phase) after thallium injection with a
large field of view gamma camera (CAMSTAR
3000; General Electric, USA) equipped with a
low-energy, all-purpose collimator. The detector
collected data through a 180-degree arc from the
45-degree right anterior oblique to the 45-degree
left posterior oblique position. Contiguous trans-
axial tomograms were reconstructed into 6-mm
thick multiple sections with a filtered back-
projection method with the use of a Hanning
ramp filter and a convolution algorithm without
attenuation correction. Thereafter, the tomogra-
phic images along the short and long axes of the
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left ventricle were recognized from the set of the
transaxial tomograms according to the method
described by Borrello et al.18 No patients had un-
usually large or pedunculated breasts. Therefore, no
prone position was used for thallium imaging.
All myocardial SPECT images were interpreted
qualitatively by two experienced observers who
were unaware of the ECG or angiographic results.
The ventricle was divided into 10 segments.19,20
The activity of Tl-201 in each segment was scored
as 3 (normal), 2 (mildly reduced), 1 (moderately
reduced), or 0 (severely reduced). A segment was
considered abnormal in the presence of reversible
defects or a severe (score = 0) fixed defect. Stress
images were compared with redistribution images
to evaluate the presence or absence of reversible
(ischemic) or fixed defects. Our interobserver
agreement for SPECT interpretation was 96%
(κ = 0.90, SEM = 0.079).16,17
ECG interpretation
Conventional 12-lead ECG was recorded every 3
minutes during dobutamine infusion. The ECG
was interpreted at a later stage by an experienced
cardiologist who was unaware of the Tl-201 SPECT
and coronary angiographic results. Calculation of
the maximal ST/HR slope was performed by using
linear regression analysis to relate the magnitude of
ST-segment depression in each lead (except aVR,
aVL, and V1) to heart rate as previously reported
in detail.21,22 The ST/HR slope was calculated by
a digitizing computer and the highest ST/HR
slope with a significant coefficient of correlation
among all the leads was taken as the test result. 
A slope of ≥ 2.0 µV/beats/min was considered a
“positive” test.23,24
Coronary angiography
Coronary angiography was performed with the
Judkins’ technique. A computer-aided quantitative
coronary angiographic analysis system (DCI-S
Automated Coronary Analysis System; Philips
Medical System, Eindohoven, Netherlands) was
used to calculate the percentage of stenosis. A
≥ 50% diameter stenosis was considered signifi-
cant. Left main lesion was considered equivalent
to the left anterior descending and left circumflex
lesions.
Statistical analysis
All continuous data are expressed as mean ±
standard deviation (SD). Sensitivity, specificity,
positive predictive value, negative predictive value
and accuracy were all calculated with standard for-
mulas. All statistical differences among the groups
were obtained with the Student’s t test and the 
χ2 test. A value of p < 0.05 was considered to be
statistically significant.
Results
Baseline characteristics
A total of 51 female patients were included for
analysis. The mean age was 63 ± 9 years. Among
them, 36 patients (71%) had hypertension, 13
(26%) had diabetes mellitus, four (8%) smoked
and 20 (39%) had hyperlipidemia. Pathologic Q
waves in the resting ECG, previous myocardial
infarction history or both were observed in seven
patients (14%), and 24 patients (47%) were 
on β-blockers. Twenty-eight patients (55%) had
CAD documented by angiography. Among them,
11 patients (39%) had one-vessel disease, eight
patients (29%) had two-vessel disease and the
remaining nine patients (32%) had three-vessel
disease.
Reasons for termination and side effects of
dobutamine infusion
The reasons for the termination of dobutamine
infusion were as follows: completion of the max-
imal dose of 40 µg/kg/min in 33 (64%) patients,
85% of age-predicted maximal heart rate in 11
(22%) patients, prolonged chest pain in three
(6%) patients, intractable headache in two (4%)
patients, severe hypertension in one (2%) patient,
and symptomatic hypotension in one (2%) pa-
tient. The most frequent complications were pre-
mature ventricular contractions (24%) and chest
pain (18%), followed by palpitation (16%), fre-
quent atrial premature contractions (12%),
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headache (8%), hypotension (4%), non-sustained
ventricular tachycardia (2%), and yawning (2%).
Dobutamine ST/HR slope versus dobutamine
Tl-201 SPECT in detecting CAD
The baseline heart rate was 67 ± 13 beats/min
and the heart rate was significantly enhanced
after dobutamine infusion (110 ± 22 beats/min,
p < 0.001). Mean systolic blood pressure was 129 ±
18 mmHg at baseline and 155 ± 30 mmHg at peak
dobutamine dose (p < 0.001). The diagnostic effi-
cacy of dobutamine ST/HR slope, Tl-201 SPECT
and the combination of both methods are shown
in Table 1. The overall diagnostic sensitivity of
dobutamine ST/HR slope was significantly worse
than that of Tl-201 SPECT in detecting CAD (43%
vs. 71%, p = 0.028), but the specificity was similar
to that of Tl-201 SPECT (83% vs. 87%, p > 0.05).
In addition, the sensitivity and specificity of ST/HR
slope for detecting single- or multivessel disease
were also worse than those of Tl-201 SPECT. Using
both positive results of Tl-201 SPECT and ST/HR
slope in detecting CAD, the diagnostic specificity
was increased form 87% to 96%. Using both neg-
ative results of Tl-201 SPECT and ST/HR slope to
exclude CAD, the negative predictive value was
increased from 71% to 85% (Table 1).
Diagnostic values of dobutamine ST/HR
slope in women with different pretest
likelihood
To analyze whether the diagnostic values of dobu-
tamine ST/HR slope in women is affected by the
pretest likelihood, we divided our patients into
two groups: group 1 with > 50% pretest likeli-
hood, and group 2 with ≤ 50% pretest likelihood
(Table 2). Thirty-two patients in group 1 and 19
patients in group 2 were subjected to further
analysis. The diagnostic sensitivity of dobutamine
ST/HR slope in groups 1 and 2 was 50% and 33%,
respectively (p > 0.05), while diagnostic specificity
was 80% and 69%, respectively (p > 0.05), and di-
agnostic accuracy was 59% and 58%, respectively
(p > 0.05).
Table 1. Comparison of the diagnostic performance of dobutamine ST-segment/heart rate (ST/HR) slope,
thallium-201 single-photon emission computed tomography (SPECT) and combination of both
ST/HR slope (n = 51) SPECT (n = 51) Combination (n = 51)
Sensitivity 12/28 (43%)* 20/28 (71%) 25/28 (89%)†
1- or 2-vessel disease 7/19 (37%) 12/19 (63%) 16/19 (84%)
3-vessel disease 5/9 (56%) 8/9 (89%) 9/9 (100%)
Specificity 19/23 (83%) 20/23 (87%) 22/23 (96%)‡
PPV 12/16 (75%) 20/23 (87%) 25/31 (81%)
NPV 19/35 (54%) 20/28 (71%) 17/20 (85%)
Accuracy 31/51 (61%) 40/51 (78%) 42/51 (82%)
*p = 0.028 vs. SPECT; †either ST/HR slope or SPECT showed abnormal results; ‡both ST/HR slope and SPECT showed normal results.
PPV = positive predictive value; NPV = negative predictive value.
Table 2. Diagnostic sensitivity, specificity and accuracy in patients with different pretest likelihood of
coronary artery disease by dobutamine ST-segment/heart rate slope
Sensitivity Specificity Accuracy
Patients with different pretest likelihood
Group 1 (> 50% pretest likelihood) 11/22 (50%) 8/10 (80%) 19/32 (59%)
Group 2 (≤ 50% pretest likelihood) 2/6 (33%) 9/13 (69%) 11/19 (58%)
p NS NS NS
NS = no significant difference between group 1 and group 2.
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Influence of b-blockers on diagnostic values
of ST/HR slope and dobutamine thallium
SPECT
Because β-blockers might decrease the sensitivity
of a dobutamine stress test by decreasing maximal
achieved heart rate,1 it is essential to assess the
diagnostic values of dobutamine ST/HR slope in
patients taking or not taking β-blockers. The pa-
tients were divided into two subgroups according
to whether they were receiving (group A) or not
receiving (group B) β-blockers (Table 3). The sen-
sitivity of dobutamine ST/HR slope for detecting
CAD in groups A and B were 53% and 31%, re-
spectively (p > 0.05). The sensitivity of dobuta-
mine Tl-201 SPECT in groups A and B were 67%
and 77%, respectively (p > 0.05). The specificity
of dobutamine ST/HR slope with CAD in groups
A and B were 56% and 86%, respectively (p> 0.05).
The specificity of Tl-201 SPECT in groups A and
B were 78% and 93%, respectively (p > 0.05). In
addition, the diagnostic sensitivity and speci-
ficity of dobutamine Tl-201 SPECT were signifi-
cantly higher than those of ST/HR slope in both
group A and group B (p < 0.05; Table 3).
Discussion
This is the first report showing the diagnostic ef-
ficacy of dobutamine ST/HR slope in detecting
CAD in women. The diagnosis of CAD in women
presents a greater challenge than in men. Several
factors may limit the diagnostic efficacy of exercise
ECG in women, including lower prevalence and
less severe coronary lesions,3–6 as well as being
generally older at the time of CAD diagnosis com-
pared to men. Most of our patients (78%) failed to
achieve 85% of maximal heart rate under dobu-
tamine infusion and the conventional ST-segment
depression criteria were obviously ineffective in
detecting CAD in the present study. Therefore, we
chose to use ST/HR slope rather than the conven-
tional ST-segment criteria as a diagnostic index to
detect CAD in women. Early studies have recog-
nized that a proportional relationship occurs be-
tween ST-segment depression and changing heart
rate during myocardial ischemia.25 Later investiga-
tions also confirm that temporal changes in ST-
segment and heart rate could be linearly related
and can be quantified as a slope by linear regres-
sion analysis at a higher level of exercise.26,27 Maxi-
mal exercise-induced ST/HR slope provides a better
diagnostic performance than by using changes in
ST-segment alone, because it adjusts changes in
ST-segment depression with changing heart rate,
which is well correlated with changes in myo-
cardial oxygen demand.26–28 Okin and Kligfield
demonstrated that ST/HR slope could improve the
diagnostic accuracy of exercise ECG for detecting
CAD in women compared to conventional ST-
segment criteria.21 Our previous study showed
that ST/HR slope could improve the diagnostic
accuracy of exercise ECG, especially in subjects
with lower peak heart rate.29 However, the co-
morbidities associated with age, such as neuro-
logic deficits, orthopedic and peripheral vascular
Table 3. Influence of β-blocker on diagnostic sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) and accuracy of dobutamine ST-segment/heart rate (ST/HR) slope and
thallium-201 single-photon emission computed tomography (SPECT) scan
Group A (n = 24) Group B (n = 27)
p
ST/HR slope SPECT ST/HR slope SPECT
Sensitivity 8/15 (53%) 10/15 (67%) 4/13 (31%) 10/13 (77%) NS
Specificity 5/9 (56%) 7/9 (78%) 12/14 (86%) 13/14 (93%) NS
PPV 8/12 (75%) 10/12 (83%) 4/6 (67%) 10/11 (91%) NS
NPV 5/12 (42%) 7/12 (58%) 12/21 (57%) 13/16 (81%) NS
Accuracy 13/24 (54%) 17/24 (71%) 16/27 (59%) 23/27 (85%) NS
Group A = treated with b-blockers; Group B = not treated with b-blockers; NS = no significant difference between groups A and B.
problems, also limit the level of maximal exercise
and the extent of exercise-induced myocardial is-
chemia.10 When present, these factors would favor
pharmacological stress thallium scan as a diag-
nostic tool, such as dobutamine. However, Tl-201
SPECT scan also has some disadvantages. On 
average, women’s hearts and arteries are smaller
than men’s and are difficult to image.30 Further-
more, left breast attenuation with depressed count
density of the anterior wall of the left ventricle
often causes false-positive results in women.13,31
Therefore, several methods have been developed
to correct these artifacts and have yielded in-
cremental diagnostic values either by directly
measuring the attenuation in soft tissue with a
transmission source14 or by using a dual-isotope
myocardial imaging technique.32 However, these
methods require expensive hardware and a much
longer imaging time.
In the present study, the overall diagnostic sen-
sitivity of dobutamine ST/HR slope was similar
to that of dobutamine ECG by using ST-segment
criteria for CAD diagnosis,33,34 but was lower
than previous studies regarding exercise ST/HR
slope,21,33,34 suggesting that dobutamine ST/HR
slope may not be a good alternative to exercise
ST/HR slope for detecting CAD in women. It has
been shown that dobutamine induces lower car-
diac stress intensity (rate–pressure product) than
exercise.35,36 In addition, less than 20% of our
study patients achieved 85% of the age-predicted
maximal heart rate under dobutamine infusion
and only 64% of the patients received the maxi-
mal dose of dobutamine. The lower and hetero-
geneous stress intensity are possible reasons that
may attenuate the diagnostic efficacy of dobuta-
mine ST/HR slope in detecting CAD in women
because the ability to provoke myocardial ischemia
is proportional to peak cardiac stress.
The sensitivity of dobutamine Tl-201 SPECT
in detecting CAD was similar to that reported by
Taillefer et al30 and Ho et al.37 The specificity of
dobutamine Tl-201 SPECT in detecting CAD
ranged from 56% to 91%.30,37,38 A slightly higher
specificity was noted in the present study. This is
probably due to the fact that oriental female 
patients rarely have large or pedunculated breasts.
Breast and soft tissue artifacts in women may 
be accentuated by tomographic imaging, leading
to a lower specificity. Despite the diagnostic per-
formance of dobutamine ST/HR slope being un-
satisfactory, we assessed whether it has additional
diagnostic value when combined with Tl-201
SPECT scan. Using both positive results of both
Tl-201 SPECT and ST/HR slope for diagnosing
CAD, we found that the diagnostic specificity in-
creased from 87% to 96%. Using both negative
results of Tl-201 SPECT and ST/HR slope to 
exclude CAD, the negative predictive value also
increased, from 71% to 85%. Thus, our data
demonstrated that dobutamine ST/HR slope had
additional diagnostic benefits to Tl-201 SPECT
without requiring extra hardware or imaging time.
In addition, the sensitivity and specificity of dobu-
tamine ST/HR slope for detecting CAD were nei-
ther affected by the pretest likelihood of CAD
nor by β-blockers.
There are several limitations in our study. First,
this study was performed in a selected popula-
tion primarily referred for coronary angiography.
The diagnostic sensitivity of dobutamine ST/HR
slope in detecting CAD in women would be af-
fected by the higher prevalence rate in our study
patients and these results may not be applicable
to a general population. However, inclusion of
catheterized patients is necessary to validate the
significance of changes in ST/HR slope on dobu-
tamine ECG. Second, most of our study patients
failed to achieve 85% of the age-predicted maximal
heart rate under dobutamine infusion and only
64% of the patients received the maximal dose
of dobutamine. The lower stress intensity and
heterogeneous dosing of dobutamine may atten-
uate the diagnostic performance of dobutamine
ST/HR slope in detecting CAD in women.
Although exercise ST/HR slope has been shown
to improve the efficacy of CAD diagnosis in
women, our data indicate that dobutamine ST/HR
slope has significantly lower diagnostic sensitivity
and specificity when compared with Tl-201 SPECT
scan. The unsatisfactory diagnostic efficacy sug-
gests that dobutamine ST/HR slope may not be 
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a good alternative to exercise ECG. However, with
simple computerized calculation, dobutamine
ST/HR slope enhances both the sensitivity and
specificity for detecting CAD in women when
combined with Tl-201 SPECT.
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